Introduction
NADPH oxidases (Noxs) are a family of reactive oxygen speciesgenerating (ROS-generating) enzymes with diverse pathophysiological roles (1) . The prototypic member of this family, Nox2, was first identified in neutrophils, where it is involved in the killing of phagocytized microorganisms. Nox2 is also expressed in other leukocytes and many nonhematopoietic cells, such as cardiomyocytes and endothelial cells, where it modulates redox-sensitive signaling pathways (2) . Cellular Nox2 activation requires the assembly of membrane-bound and cytoplasmic subunits into a multiprotein complex that transfers electrons from NADPH to molecular oxygen, a process that is stimulated by agonists such as angiotensin II (Ang II) (1) .
Increased activation of the renin-angiotensin system is a major stimulus for pathological cardiovascular remodeling, contributing to hypertension, endothelial dysfunction, cardiac hypertrophy, and heart failure (3), and previous work has shown an important role for Nox2 in amplifying these processes (1, 2) . Recent studies indicate that Nox2 has distinct roles in different cell types, and cell-specific contributions of endothelial cell and cardiomyocyte Nox2 to Ang IIdependent cardiovascular remodeling have been reported (4) (5) (6) . It has long been known that Nox2 is also expressed in T cells (7) , but relatively little is known about the T cell-specific function of Nox2 in Ang II-dependent hypertension and cardiovascular remodeling.
Previous work found that Ang II stimulates the synthesis of proinflammatory cytokines, chemokines, and adhesion molecules in the heart and vessels, inducing the recruitment and activation of T and B lymphocytes and dendritic and natural killer cells (8) . In this setting, emerging evidence suggests that T cells participate in the genesis of hypertension (9) . For instance, humanized mice in which the murine immune system was replaced by human leukocytes showed greater hypertension after Ang II infusion along with increased infiltration of CD4 + cells in the aorta and kidney (10) . Circulating CD4 + T cells from hypertensive patients produced more IFN-γ than cells from normotensive subjects, while in mice the inhibition of the B7/CD28 costimulatory axis with CTLA-4-Ig (cytotoxic T lymphocyte-associated protein 4, also called CD152) attenuated Ang II-induced hypertension and T cell accumulation in the aorta (10, 11) . Specific T cell subsets also influence cardiac remodeling; for example, CD4
+ but not CD8 + T cells are reported to promote the transition from pressure overload cardiac hypertrophy to failure (12) . The importance of ROS in T cell functions in hypertension has been suggested by prior studies. It was found that mice lacking T and B cells (Rag1 -/-) displayed blunted hypertensive responses to chronic Ang II infusion, and that the hypertensive response was restored after adoptive transfer of Nox2-competent T cells (13) . It was also shown that Ang II-stimulated increase in TNF-α production by T cells was inhibited by scavenging ROS (14) . However, the specific role of different Nox2-containing T cell subsets remains unknown.
The superoxide-generating enzyme Nox2 contributes to hypertension and cardiovascular remodeling triggered by activation of the renin-angiotensin system. Multiple Nox2-expressing cells are implicated in angiotensin II-induced (Ang II-induced) pathophysiology, but the importance of Nox2 in leukocyte subsets is poorly understood. Here, we investigated the role of Nox2 in T cells, particularly Tregs. Mice globally deficient in Nox2 displayed increased numbers of Tregs in the heart at baseline, whereas Ang II-induced effector T cell (Teff) infiltration was inhibited. To investigate the role of Treg Nox2, we generated a mouse line with CD4-targeted Nox2 deficiency (Nox2 of Ang II on the heart, as these changes persist when blood pressure is normalized with the antihypertensive agent hydralazine (Supplemental Figure 1 ; supplemental material available online with this article; https://doi.org/10.1172/JCI97490DS1). We first studied the time course of cardiac T cell infiltration during chronic Ang II infusion. Immunostaining of cardiac sections revealed CD3 + cell infiltration as early as 3 days after Ang II treatment, with the cells being in perivascular clusters at days 3-7, whereas by day 14 leukocytes were mainly interstitial ( Figure 1D ). Flow cytometry analyses revealed a peak of CD45 + TCRβ + cells after 3 days of Ang II treatment, comprising both CD4 + and CD8 + T cells (Figure 1 , E-G). 
Deficiency of Nox2 inhibits cardiac T cell infiltration in

Results
Myocardial T cell infiltration occurs in a time-dependent manner during Ang II treatment. Chronic Ang II infusion (1.1 mg/kg/d for 14 days) induces significant hypertension, cardiac hypertrophy, and interstitial fibrosis in mice (Figure 1 , A-C), as previously described (15, 16) . A substantial component of the cardiac hypertrophy and fibrosis in this model is related to direct effects These results suggest that Nox2 deficiency results in enhanced Treg numbers in the heart under basal conditions and after Ang II treatment, which may limit infiltration by Teffs and cardiovascular remodeling induced by Ang II.
In In (22) , synthesis of adenosine by coordinated activity of the ectoenzymes CD39 and CD73 (23, 24) , and direct induction of apoptosis of CD4 + or CD8 + Teffs (25) . We found that Nox2-deficient Tregs expressed higher levels of mRNA for CTLA-4, CD39, and CD73 than WT Tregs ( Figure 5, D-F) . Addi- tionally, Nox2-deficient Tregs expressed higher mRNA levels of the glucocorticoid-induced TNF-related receptor (GITR) ( Figure  5G ), which has previously been shown to be related to proliferation and maintenance of the suppressive phenotype of Tregs (26) . Increased protein levels of CTLA-4, CD39, CD73, and GITR in Nox2-deficient versus WT Tregs were further confirmed by flow cytometry (Supplemental Figure 8) . Substantial evidence indicates that the forkhead box P3 transcription factor, FoxP3, plays a critical role in the development and function of CD4 + CD25
+ Tregs. Mutations of human FoxP3 result in dysfunction or impaired development of Tregs and lead to immunodysregulation and diverse immune disorders (27, 28) . Here, we first observed by imaging flow cytometry, confocal microscopy, and immunoblotting that Tregs deficient in Nox2 had increased nuclear levels of FoxP3 under basal conditions ( Figure  7A and Supplemental Figure 9 ). It was previously reported that FoxP3 associates with the NF-κB subunit p65 (also known as RelA) on the CD25 promoter, mediating the transcription of the CD25 gene (also known as IL-2 receptor α chain or IL2RA) (29) , and that an NF-κB-dependent transcriptional program promotes Treg identity and function (30) . In addition, we recently demonstrated that the deficiency of Nox2 increases nuclear NF-κB activation in myeloid cells, secondary to changes in nuclear redox state (31) . In line with these reports, we observed an enhanced colocalization of FoxP3 and p65 in stimulated Nox2-deficient versus WT Tregs ( Figure 7B ). Moreover, Nox2-deficient Tregs had higher nuclear p65 levels after anti-CD3 plus anti-CD28 stimulation than WT Tregs, as evaluated by imaging flow cytometry and confocal microscopy ( Figure 7, C and D) . More direct assessment of NF-κB transcriptional activity was undertaken in Jurkat cells transfected with an NF-κB firefly reporter construct. In these cells, the inhibition of Nox2 by preincubation with gp91ds-tat (a selective peptide inhibitor of Nox2) resulted in a higher NF-κB activation after TNF-α stimulation than in cells preincubated with a scrambled peptide control (scrambled-tat) ( Figure 7E ). Finally, we found that Nox2-deficient Tregs expressed higher levels of CD25 mRNA ( Figure 7F) , consistent with the increased nuclear levels of FoxP3 and p65. Also, there was enhanced phosphorylation of STAT5 after stimulation with IL-2 (as a readout of functional CD25 activity) in Nox2-deficient Tregs compared with WT Tregs (Figure 7G) .
Therefore, the increased suppressive activity of Nox2-deficient Tregs may be related to their increased nuclear levels of FoxP3 and enhanced NF-κB activation, which drives an increased expression of CD25 and other molecules mediating suppression of Teffs. test (A, B, and F) , 2-way ANOVA (G), or 1-way ANOVA followed by Tukey's post-test (C and E); n = 3 independent experiments except where shown otherwise. jci.org Volume 128 Number 7 July 2018 the higher suppressive activity of Nox2-deficient Tregs involves enhanced nuclear levels of FoxP3 and NF-κB activation, which may drive the expression of the IL-2 receptor CD25 and its downstream signaling via STAT5 phosphorylation ( Figure 9 ). Despite Nox2 being expressed in multiple cell types that are potentially involved in Ang II-dependent pathology, we find that targeted inhibition of Nox2 in Tregs is sufficient to significantly ameliorate Ang II-induced hypertension and heart remodeling. T cells express the Ang II receptor AT1, which is known to enhance T cell proliferation and modulate inflammatory responses (32, 33) . The importance of T cells in the pathogenesis of hypertension has been recognized for many years, with most studies focusing on the role of T cells in aggravating hypertension, vascular remodeling, and renal dysfunction (10, 11, 13, 34) . Moreover, the contribution of T cells to cardiac remodeling has been increasingly recognized during hypertension or pressure overload (12, 35) . More recently, it has been found that Tregs (CD4 + CD25 + FoxP3 + ) can act to limit Ang II-induced inflammation and damage in the vasculature and heart, thereby reducing the extent of hypertension and cardiac remodeling (36) (37) (38) (39) (40) . However, the mechanisms that control these suppressive actions of Tregs in hypertension and cardiac remodeling were unclear. In the present study, we observe that Tregs were injected into WT mice immediately before initiation of Ang II infusion. Animals treated with either WT or Nox2 -/y Tregs had lower numbers of CD4 + and CD8 + T cells in the heart as compared with saline-treated controls (Figure 8, A and B) . Mice that received Nox2 -/y Tregs had a higher percentage of Tregs in the heart after Ang II treatment than mice injected with WT Tregs ( Figure 8C ). Adoptive transfer of Tregs, either WT or Nox2 -/y , inhibited Ang II-induced hypertension, cardiac fibrosis, and cardiomyocyte hypertrophy (Figure 8, D-G) . Notably, the adoptive transfer of Nox2-deficient Tregs induced a greater inhibition of Ang II-induced hypertension and heart fibrosis than was observed with the adoptive transfer of WT Tregs (Figure 8, D and E) . Therefore, Tregs deficient in Nox2 are more protective than WT Tregs in the setting of hypertension and cardiac remodeling.
Discussion
The major novel finding of this study is that the expression of Nox2 in CD4
+ Tregs plays a vital role in their function to orchestrate Ang II-induced hypertension and cardiac remodeling. We show that Nox2 in Tregs limits their suppressive activity and therefore allows an increase in the infiltration/proliferation of Teffs, including Th17 cells, which enhances Ang II-induced hypertension, cardiac fibrosis, and hypertrophy. Mechanistically, lymphocytes, synergizes with p65 on a regulatory region of the CD25 promoter to mediate the transcriptional activation of the CD25 gene (29) . We find increased CD25 expression in Nox2-deficient Tregs, and, in keeping with this, these cells have higher levels of phosphorylated STAT5 compared with WT Tregs after IL-2 stimulation. The crucial role of IL2R/STAT5 signaling in Treg-suppressive function has recently been highlighted by the demonstration that ablation of STAT5 signaling compromised Treg suppression in vitro and in vivo (41) . Moreover, Tregs with enhanced STAT5 activation express higher levels of proteins involved in cell adhesion, which results in higher interaction with dendritic cells and blockade of costimulatory molecule synthesis. It is also well established when Nox2 is deficient in Tregs, they are more suppressive in vitro, accumulate in the heart at baseline, and are protective against Ang II-induced hypertension and heart remodeling.
We investigated the mechanisms that may underlie the greater suppressive effects of Nox2-deficient compared with WT Tregs (defined as CD4
+ cells). Nox2-deficient Tregs are found to have increased expression levels of CTLA-4, CD39, CD73, and GITR, which are all involved in suppression through different mechanisms (22) (23) (24) . Nox2-deficient Tregs also exhibit higher nuclear levels of FoxP3 and the p65 subunit of NF-κB, which could drive the transcription of CD25. Indeed, previous studies have shown that FoxP3, induced by CD28 signaling in human CD4 + T Figure 9 . Schematic of cellular and molecular mechanisms through which Nox2 in CD4 + T cells regulates Ang II-induced hypertension and heart remodeling. Deficiency of Nox2 in Tregs results in increased numbers of Tregs in the heart and vessels and protects against the development of hypertension, interstitial cardiac fibrosis, and cardiomyocyte hypertrophy. Mechanistically, the deficiency of Nox2 in Tregs enhances their suppressive function through an increase in nuclear levels of FoxP3 and NF-κB activation, and higher levels of GITR, CTLA-4, CD39, CD73, and CD25. The higher CD25 levels may drive an increased STAT5 phosphorylation under IL-2 stimulation, and lead to a positive feedback promoting suppression. The deficiency of Nox2 also drives a change in balance between Tregs and Th17 cells to a more antiinflammatory profile, with higher IL-10 and lower IL-17 levels.
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jci.org Volume 128 Number 7 July 2018 (4-6, 46, 47) . The involvement of Nox2-expressing T cells in Ang II-induced hypertension was suggested in a study in which the adoptive transfer of T cells into RAG-deficient mice (which lack T and B cells) restored hypertensive responses to Ang II, with full manifestation of this requiring T cells with a functional Nox2 (13) . However, the role of different T cell subsets was not explored. Recently, it was reported that during Ang II-stimulated hypertension there is an accumulation of oxidatively modified isoketal-protein adducts in dendritic cells, which activate these cells and promote CD8 + T cell activation/proliferation and hypertension (48) . Nox2 in dendritic cells may contribute to the formation of these oxidation products, and it was previously shown that dendritic cell Nox2 is involved in antigen presentation via MHC class II as a consequence of regulating phagosomal pH (49) . In the current study, we identify, for the first time to our knowledge, a pivotal role of Nox2 in Tregs in regulating Ang II-induced hypertension and cardiac remodeling. Remarkably, Nox2 deletion solely in Tregs in adoptive transfer studies is sufficient to induce substantial inhibition of Ang II-induced hypertension and particularly interstitial cardiac fibrosis, pointing to the importance of Treg Nox2 in these processes. We observed increased numbers of Nox2-deficient Tregs in the heart, aorta, and kidney during Ang II infusion. It is likely that both vascular and renal Treg infiltration may contribute to the changes in Ang II-induced hypertension (although we do not find significant changes in renal function in Nox2 fl/fl CD4Cre + mice). The changes in Ang II-induced cardiac fibrosis and remodeling are likely to be due in large part to the direct effects of Tregs in the heart rather than secondary to the change in blood pressure, since cardiac fibrosis and remodeling are to a significant extent independent of hypertension in this model (Supplemental Figure 1) .
In conclusion, this study uncovers a crucial role of Nox2 in CD4
+ Tregs in regulating Ang II-induced hypertension and cardiac remodeling. The current results suggest that targeting Nox2 in Tregs might be a useful strategy in cardiovascular diseases. Given that Treg-based cell therapy is already in early clinical trials in transplant rejection (50) , and that several approaches to Nox2 inhibition are feasible, studies to investigate the impact of Treg Nox2 in such pathological settings are also warranted.
Methods
Mice and in vivo studies. All studies were performed in 6-to 8-week-old male mice on a C57BL/6J background. Globally Nox2-deficient mice (Nox2 Gene-modified mice were compared with matched WT littermates. Ang II (1.1 mg/kg/d) was infused via subcutaneous osmotic minipumps (model 1002, Alzet) implanted under 2% isoflurane anesthesia. Blood pressure was determined by the tail cuff method (MK-2000ST, Muromachi Kikai). Echocardiography was performed in mice under 1.5% isoflurane anesthesia using a VisualSonics Vevo 2100 imaging system (FUJIFILM) (5) . Renal function was assessed in response to an acute i.p. saline challenge in a metabolic cage (6) . Metabolites were analyzed on an Advia 2400 Chemistry System (Siemens AG).
Flow cytometry. Hearts were perfused with 0.9% NaCl through the left ventricle before harvesting. Single-cell suspensions were prepared by digestion of heart, kidney, or aorta in a mixture of collagenase (1 mg/ml; catalog C5238, Sigma-Aldrich), DNase (160 IU/ml), that STAT5 activation in Tregs correlates with FoxP3 expression and their proliferative capacity (41) , which in Nox2-deficient Tregs might generate a positive feedback of suppression.
The enhanced NF-κB activation in Nox2-deficient Tregs is rather analogous to findings that we and others have reported in macrophages, where Nox2 deficiency results in hyperactivation of NF-κB in response to lipopolysaccharide (31, 42) . We showed that the increased NF-κB activation is related to a Nox2-dependent regulation of nuclear redox state (31) , and it is conceivable that a similar mechanism may contribute to the increase in nuclear p65 and FoxP3 levels observed in the current study. Previous work has shown the importance of NF-κB in the development and suppressive function of Tregs, at least in part through the regulation of transcription of FoxP3 and CD25 (29, 30, 43, 44) . Therefore, it is likely that the increased nuclear levels of FoxP3 and NF-κB in Nox2-deficient Tregs contribute to their higher suppressive capacity.
Interestingly, at least part of the effect of Nox2-deficient Tregs is related to a greater inhibition of Th17 cells, which are found in reduced numbers in Nox2 
CD4Cre
+ compared with Nox-2 fl/fl mice after Ang II infusion, indicating a switch from a pro-to an antiinflammatory phenotype when Nox2 is deleted in Tregs. Our in vitro coculture studies suggest that the reduction in IL-17 levels is not related to a deficiency of Nox2 in Teffs but reflects the effects of Nox2-deficient Tregs ( Figure 5H) , consistent with the idea that there is a regulatory interplay between Tregs and Th17 cells (19) .
In addition to an increase in CD4 In the present study, we also find that the hearts of Nox2 fl/ fl CD4Cre + mice express modestly higher levels of c-Met, CCR4, and CXCR3 mRNA than WT littermate hearts. Interestingly, CXCR3-positivity is reported to identify CD4 +
FoxP3
+ Tregs with enhanced homing and suppressive capacity (45) , while a recent study showed that a c-Met
+ phenotype is a specialized homing "signature" to instruct T cell cardiotropism (17) . We speculate that these changes may contribute, at least in part, to the higher number of Tregs found in the hearts, aortae, and kidneys of Nox2 fl/fl
CD4Cre
+ compared with control mice as well as the higher proportion of Nox2-deficient compared with WT Tregs found in the hearts of WT mice after adoptive transfer.
Previous studies showed that Nox2 expressed in cardiomyocytes, endothelial cells, and neurons contributes to the pathophysiology of Ang II-induced hypertension and cardiac remodeling and thymidine kinase Renilla luciferase constructs (phRL-TK, Promega) using electroporation in T cell nucleofector media (Lonza). Plasmids expressing minimal promoter firefly and thymidine kinase Renilla were used as controls. Luciferase activities in cell lysates were determined using the Dual-Glo luciferase system (Promega) in a plate luminometer (Mithras LB 940, Berthold).
Immunofluorescence and ImageStream. Levels of nuclear p65 and FoxP3 were evaluated in CD4 + CD25
+ T cells after stimulation with anti-CD3 (2 μg/ml) plus anti-CD28 (4 μg/ml). Cells were fixed with paraformaldehyde 4% and stained with anti-p65 Ab (catalog sc-372, Santa Cruz Biotechnology) and anti-mouse FoxP3 Ab (catalog 14-5773-82, eBioscience) and then with Alexa Fluor 488 anti-rabbit Ab and Alexa Fluor 633 anti-rat Ab. Nuclei were stained with DAPI (Sigma-Aldrich). Cell images were acquired by confocal microscopy (Leica TCS SP5). Levels of nuclear FoxP3 and p65 and colocalization of FoxP3/p65 in CD4 + T cells purified from Nox2 -/y and WT mice were also determined using imaging flow cytometry. CD4 + T cells were stimulated with anti-CD3 (4 μg/ml) plus anti-CD28 (4 μg/ml) for 60 minutes and stained with anti-CD4-PE/Cy7 (catalog 25-0041-82, eBioscience) for 30 minutes. Cells were then fixed, permeabilized, and stained with anti-FoxP3-APC, rabbit anti-p65, DAPI, and goat Alexa Fluor 488 anti-rabbit Ab. Cell images were acquired in ImageStreamX MKII (Merck Millipore) and analyzed using IDEAS 6.2 software (NIH). Nuclear translocation and colocalization wizards available in the software guided the analyses. Parameters were evaluated in CD4 + FoxP3 + cells (500-5,000 cells per group). The coefficient of similarity (Cs) was defined as "Similarity" or "Bright field similarity" in channels corresponding to FoxP3, DAPI, and p65. Cytokine production and immunoblotting. Levels of TNF-α and IFN-γ were determined in supernatants of cocultures of Teffs and Tregs using a Cytometric Bead Array kit (BD Pharmingen). Levels of IL-17 and IL-10 were determined by ELISA using kits from R&D Systems and eBioscience, respectively.
Nuclear protein from purified Tregs was immunoblotted for FoxP3 (catalog 145773-82, eBioscience) and histone H3 (catalog 4499S, Cell Signaling Technology) using standard methods. Anti-rabbit 680VW and anti-rat 800VW Licor Abs (catalog 925-68071 and 925-32219, respectively) were used as secondary Abs. Signals were analyzed using the Odyssey CLx infrared Imaging System.
Histology. Leukocyte infiltration, cardiomyocyte hypertrophy, and fibrosis were analyzed in paraffin-embedded sections stained with H&E, wheat germ agglutinin, and Picrosirius red, respectively. Cryoand hyaluronidase (500 IU/ml) at 37°C for 30 minutes. Samples were triturated and sequentially filtered through a 40-μm nylon mesh. Red blood cells were lysed in 2% NH 4 Cl buffer. Nonspecific interactions were blocked with anti-mouse CD16/CD32 Ab (10 μg/ml, 1:50; catalog 14-0161-82, eBioscience) before staining. Anti-CD8-APC-Cy7, anti-CD45-FITC, anti-TCRβ-PE-Cy7, anti-MHC II-PerCP, anti-RORγT-BV421, anti-Nox2, anti-CD25-PE, anti-phospho-STAT5 Abs and anti-CD4 PercP were purchased from BD Pharmingen (catalog 561967, 553080, 560729, 562363, 562894, 611414, 553075, 562077, and 553052 respectively). Anti-CD4-eFluor450 and anti-FoxP3-APC Abs were acquired from eBioscience (catalog 48-0041-80 and 17-5773-82, respectively). Anti-rat Alexa Fluor 633 and anti-rabbit Alexa Fluor 488 were acquired from Invitrogen (catalog A21094 and A3273, respectively). The FoxP3 Transcription Factor Staining Buffer Set kit was from eBioscience (catalog 00-5523-00).
In order to determine the protein levels of CTLA-4, CD39, CD73, and GITR, Tregs were purified from lymph nodes and spleens using a Dynabeads FlowComp Mouse CD4 were purified from spleen and lymph nodes. APCs were obtained by incubation of total splenocytes with anti-CD4 and anti-CD8 Abs, followed by negative selection using Dynabeads from the Dynabeads Untouched Mouse CD4 Cells kit. Teffs were stained with CFSE (51) and incubated with Tregs under stimulation by anti-CD3ε (4 μg/ml) and APCs (1:2).
Quantitative PCR. RNA was extracted using RNeasy Mini Kits (Qiagen). After cDNA generation, SYBR Green real-time PCR was performed using the ΔΔCt method and β-actin for normalization. Primers were as follows: Nox2: forward ACTCCTTGGGT-CAGCACTGG, reverse GTTCCTGTCCAGTTGTCTTCG; CCR4: forward ATCCTGAAGGACTTCAAGCTCCA, reverse AGGTCT-GTGCAAGATCGTTTCATGG; c-Met: forward TCCTGCACTGT-
